ArticleIn vivo (Athens, Greece)
Outcomes of Adjunctive Posterior Nasal Nerve Ablation With Medial Flap Inferior Turbinoplasty.
Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimInferior turbinate reduction with septoplasty effectively relieves nasal obstruction, and ablation of the posterior nasal nerve (PNN) is effective for residual hypersensitivity-related symptoms but raises concerns regarding bleeding and symptom recurrence. This study aimed to evaluate the additional clinical benefits and safety of PNN ablation when combined with septoplasty and medial flap inferior turbinoplasty. PATIENTS AND
methodsThis retrospective, single-center cohort study included adult patients who underwent medial flap inferior turbinoplasty with septoplasty, with or without additional PNN ablation. Outcomes were assessed using Sinonasal Outcome Test-22 (SNOT-22) and Total Nasal Symptom Score (TNSS) preoperatively and at early postoperative follow-up. Symptom recurrence at five months was evaluated using a severity-based analysis of SNOT-22 rhinologic items.
resultsA total of 65 patients were included (PNN RF ablation, n=41; non-PNN RF ablation, n=24). Both groups showed significant postoperative improvement in SNOT-22 and TNSS scores. Additional PNN ablation was independently associated with greater improvement in SNOT-22 scores (B=12.102,
conclusionAdditional PNN ablation was associated with greater improvement in SNOT-22 nasal symptoms after structural nasal surgery, particularly in rhinorrhea-related symptoms. Targeting the terminal branches of the posterior nasal nerve while sparing the sphenopalatine artery was associated with effective symptom control, and no major postoperative bleeding events were observed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.